Cargando…

Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeleton

OBJECTIVE: To examine the clinical features of pediatric CNS demyelination associated with positive myelin oligodendrocyte glycoprotein (MOG) antibodies and to examine the functional effects of MOG antibody on oligodendrocyte cytoskeleton. METHODS: We measured MOG antibody using a fluorescence-activ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dale, Russell C., Tantsis, Esther M., Merheb, Vera, Kumaran, Raani-Yogeeta A., Sinmaz, Nese, Pathmanandavel, Karrnan, Ramanathan, Sudarshini, Booth, David R., Wienholt, Louise A., Prelog, Kristina, Clark, Damien R., Guillemin, Gilles J., Lim, Chai K., Mathey, Emily K., Brilot, Fabienne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4202678/ https://www.ncbi.nlm.nih.gov/pubmed/25340056 http://dx.doi.org/10.1212/NXI.0000000000000012

Ejemplares similares

Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis
por: Ramanathan, Sudarshini, et al.
Publicado: (2014)

B Cell, Th17, and Neutrophil Related Cerebrospinal Fluid Cytokine/Chemokines Are Elevated in MOG Antibody Associated Demyelination
por: Kothur, Kavitha, et al.
Publicado: (2016)

Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination
por: Ramanathan, Sudarshini, et al.
Publicado: (2018)

Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination
por: Tea, Fiona, et al.
Publicado: (2019)

Pathogenesis of autoimmune demyelination: from multiple sclerosis to neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody‐associated disease
por: Lopez, Joseph A, et al.
Publicado: (2021)

Dopamine-2 receptor extracellular N-terminus regulates receptor surface availability and is the target of human pathogenic antibodies from children with movement and psychiatric disorders
por: Sinmaz, Nese, et al.
Publicado: (2016)

Failure of alemtuzumab therapy in three patients with MOG antibody associated disease
por: Seneviratne, Sinali O., et al.
Publicado: (2022)

Autoantibodies and the Immune Hypothesis in Psychotic Brain Diseases: Challenges and Perspectives
por: Pathmanandavel, Karrnan, et al.
Publicado: (2013)

Intractable Hiccup in Demyelinating Disease with Anti-Myelin Oligodendrocyte Glycoprotein (MOG) Antibody
por: Akaishi, Tetsuya, et al.
Publicado: (2016)

Effects of the Positive Threshold and Data Analysis on Human MOG Antibody Detection by Live Flow Cytometry
por: Tea, Fiona, et al.
Publicado: (2020)

Myelin Oligodendrocyte Glycoprotein (MOG)-IgG Associated Demyelinating Disease: Our Experience with this Distinct Syndrome
por: Pujari, Shripad S., et al.
Publicado: (2021)

Anti-MOG autoantibodies pathogenicity in children and macaques demyelinating diseases
por: Serguera, Che, et al.
Publicado: (2019)

Utility of CSF Cytokine/Chemokines as Markers of Active Intrathecal Inflammation: Comparison of Demyelinating, Anti-NMDAR and Enteroviral Encephalitis
por: Kothur, Kavitha, et al.
Publicado: (2016)

Overlapping central and peripheral nervous system syndromes in MOG antibody–associated disorders
por: Rinaldi, Simon, et al.
Publicado: (2020)

Combined Central and Peripheral Demyelination in a Patient of Multifocal Motor Neuropathy and Positive Anti-myelin Oligodendrocyte Glycoprotein (MOG) Antibodies
por: Elterefi, Alanood E, et al.
Publicado: (2022)

Mapping autoantigen epitopes: molecular insights into autoantibody-associated disorders of the nervous system
por: Sinmaz, Nese, et al.
Publicado: (2016)

Humoral signatures of MOG-antibody-associated disease track with age and disease activity
por: Spatola, Marianna, et al.
Publicado: (2023)

Structural and functional markers of optic nerve damage in myelin oligodendrocyte glycoprotein antibody-associated optic neuritis
por: Barnes, Stephanie, et al.
Publicado: (2021)

Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS
por: Kim, Sung-Min, et al.
Publicado: (2015)

Treatment Approaches for MOG-Ab-Associated Demyelination in Children
por: Hacohen, Yael, et al.
Publicado: (2019)

MOG antibodies in combined central and peripheral demyelination syndromes
por: Vazquez Do Campo, Rocio, et al.
Publicado: (2018)

Epitope specificity of demyelinating MOG-specific autoantibody responses
por: Brehm, U., et al.
Publicado: (1998)

International multicenter examination of MOG antibody assays
por: Reindl, Markus, et al.
Publicado: (2020)

T-cell responses to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis
por: Ewing, C., et al.
Publicado: (1998)

Differential Binding of Autoantibodies to MOG Isoforms in Inflammatory Demyelinating Diseases
por: Schanda, Kathrin, et al.
Publicado: (2021)

Refractory MOG-Associated Demyelinating Disease in a Pediatric Patient
por: Kroenke, Eve, et al.
Publicado: (2022)

Tumefactive Demyelination—A Rare Presentation of Anti-MOG Syndrome
por: Sivadasan, Sesh, et al.
Publicado: (2022)

Temporal Dynamics of MOG Antibodies in Children With Acquired Demyelinating Syndrome
por: Wendel, Eva Maria, et al.
Publicado: (2022)

Myelin Oligodendrocyte Glycoprotein (MOG) Optic Neuritis: A Case Series
por: Nurul-Ain, Masnon, et al.
Publicado: (2021)

Case Report: Anti-NMDAR Encephalitis With Anti-MOG CNS Demyelination After Recurrent CNS Demyelination
por: Ren, Bing-Yan, et al.
Publicado: (2021)

Brain histopathological study and prognosis in MOG antibody‐associated demyelinating pseudotumor
por: Shu, Yaqing, et al.
Publicado: (2019)

COVID-19 vaccine associated demyelination & its association with MOG antibody
por: Netravathi, M., et al.
Publicado: (2022)

I-AbACUS: a Reliable Software Tool for the Semi-Automatic Analysis of Invasion and Migration Transwell Assays
por: Cortesi, Marilisa, et al.
Publicado: (2018)

Influence of type I IFN signaling on anti-MOG antibody-mediated demyelination
por: Berg, Carsten Tue, et al.
Publicado: (2017)

Osmotic Demyelination: From an Oligodendrocyte to an Astrocyte Perspective
por: Nicaise, Charles, et al.
Publicado: (2019)

Attenuation of Immunogenicity in MOG-Induced Oligodendrocytes by the Probiotic Bacterium Lactococcus Sp. PO3
por: Khalifa, Ashraf, et al.
Publicado: (2023)

Defining distinct features of anti-MOG antibody associated central nervous system demyelination
por: Weber, Martin S., et al.
Publicado: (2018)

The clinical spectrum and incidence of anti-MOG-associated acquired demyelinating syndromes in children and adults
por: de Mol, CL, et al.
Publicado: (2019)

The Expanding Clinical Spectrum of Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Associated Disease in Children and Adults
por: Parrotta, Erica, et al.
Publicado: (2020)

Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Positive Patients in a Multi-Ethnic Canadian Cohort
por: Cross, Helen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8fs8pl9pun65fbgim2cs64modq